The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(3,4-Dimethoxyphenyl)-3-(pyridin-4-yl)isothiazolo[4,3-b]pyridine ID: ALA4574041
PubChem CID: 90466336
Max Phase: Preclinical
Molecular Formula: C19H15N3O2S
Molecular Weight: 349.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2cnc3c(-c4ccncc4)snc3c2)cc1OC
Standard InChI: InChI=1S/C19H15N3O2S/c1-23-16-4-3-13(10-17(16)24-2)14-9-15-18(21-11-14)19(25-22-15)12-5-7-20-8-6-12/h3-11H,1-2H3
Standard InChI Key: JVEOGZMDJDIUOL-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
16.9945 -3.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9934 -4.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7014 -4.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4111 -4.2942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4082 -3.4715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6996 -3.0662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1159 -4.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1159 -5.5192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8234 -5.9266 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8194 -4.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2867 -3.0667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6972 -2.2490 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4037 -1.8383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2865 -2.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5275 -4.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5345 -5.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3151 -5.7602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7906 -5.0939 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.3038 -4.4359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5735 -6.5321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0302 -7.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2887 -7.9184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0902 -8.0821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6327 -7.4653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3713 -6.6932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 16 1 0
15 10 1 0
10 7 2 0
4 7 1 0
1 11 1 0
6 12 1 0
12 13 1 0
11 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 15 2 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
17 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.42Molecular Weight (Monoisotopic): 349.0885AlogP: 4.44#Rotatable Bonds: 4Polar Surface Area: 57.13Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.46CX LogP: 3.24CX LogD: 3.24Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: -0.77
References 1. Wouters R, Pu SY, Froeyen M, Lescrinier E, Einav S, Herdewijn P, De Jonghe S.. (2019) Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines., 163 [PMID:30529544 ] [10.1016/j.ejmech.2018.11.065 ]